Charles Schwab’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-401,075
| Closed | -$21M | – | 3451 |
|
|
2020
Q3 | $21M | Sell |
401,075
-451,821
| -53% | -$18.7M | 0.01% | 1166 |
|
|
2020
Q2 | $28.4M | Buy |
852,896
+140,352
| +20% | +$4.47M | 0.01% | 935 |
|
|
2020
Q1 | $19.4M | Buy |
712,544
+52,534
| +8% | +$1.46M | 0.01% | 1037 |
|
|
2019
Q4 | $13M | Buy |
660,010
+69,800
| +12% | +$1.12M | 0.01% | 1506 |
|
|
2019
Q3 | $7.65M | Buy |
590,210
+17,541
| +3% | +$212K | ﹤0.01% | 1760 |
|
|
2019
Q2 | $7.13M | Buy |
572,669
+14,274
| +3% | +$190K | ﹤0.01% | 1799 |
|
|
2019
Q1 | $8.11M | Buy |
558,395
+65,445
| +13% | +$836K | 0.01% | 1715 |
|
|
2018
Q4 | $5.44M | Buy |
492,950
+62,599
| +15% | +$871K | ﹤0.01% | 1868 |
|
|
2018
Q3 | $11.3M | Buy |
430,351
+22,562
| +6% | +$610K | 0.01% | 1554 |
|
|
2018
Q2 | $8.34M | Buy |
407,789
+18,637
| +5% | +$400K | 0.01% | 1715 |
|
|
2018
Q1 | $7.06M | Sell |
389,152
-20,367
| -5% | -$340K | 0.01% | 1741 |
|
|
2017
Q4 | $5.71M | Buy |
409,519
+17,727
| +5% | +$240K | ﹤0.01% | 1864 |
|
|
2017
Q3 | $7.25M | Buy |
391,792
+33,737
| +9% | +$564K | 0.01% | 1673 |
|
|
2017
Q2 | $6.05M | Buy |
358,055
+64,817
| +22% | +$987K | 0.01% | 1692 |
|
|
2017
Q1 | $3.92M | Buy |
293,238
+43,970
| +18% | +$689K | ﹤0.01% | 1905 |
|
|
2016
Q4 | $3.75M | Buy |
249,268
+25,718
| +12% | +$340K | ﹤0.01% | 1892 |
|
|
2016
Q3 | $2.61M | Sell |
223,550
-46,571
| -17% | -$548K | ﹤0.01% | 2008 |
|
|
2016
Q2 | $2.92M | Buy |
270,121
+3,474
| +1% | +$35.8K | ﹤0.01% | 1887 |
|
|
2016
Q1 | $2.46M | Sell |
266,647
-156,337
| -37% | -$1.68M | ﹤0.01% | 1938 |
|
|
2015
Q4 | $6.28M | Buy |
422,984
+182,050
| +76% | +$3.05M | 0.01% | 1358 |
|
|
2015
Q3 | $3.95M | Buy |
240,934
+66,825
| +38% | +$1.37M | 0.01% | 1622 |
|
|
2015
Q2 | $3.97M | Buy |
174,109
+34,835
| +25% | +$694K | 0.01% | 1703 |
|
|
2015
Q1 | $2.12M | Buy |
139,274
+5,991
| +4% | +$77.8K | ﹤0.01% | 2024 |
|
|
2014
Q4 | $1.6M | Buy |
133,283
+4,326
| +3% | +$49.4K | ﹤0.01% | 2135 |
|
|
2014
Q3 | $1.46M | Sell |
128,957
-6,156
| -5% | -$70.2K | ﹤0.01% | 2126 |
|
|
2014
Q2 | $1.63M | Sell |
135,113
-506
| -0.4% | -$5.98K | ﹤0.01% | 2088 |
|
|
2014
Q1 | $1.58M | Buy |
135,619
+3,755
| +3% | +$63.6K | ﹤0.01% | 2061 |
|
|
2013
Q4 | $2.33M | Sell |
131,864
-66,364
| -33% | -$1.12M | ﹤0.01% | 1816 |
|
|
2013
Q3 | $2.98M | Buy |
198,228
+87,846
| +80% | +$1.34M | 0.01% | 1582 |
|
|
2013
Q2 | $1.65M | Buy |
+110,382
| New | +$1.46M | ﹤0.01% | 1877 |
|
Charles Schwab's MNTA Position: Q4 2020 in Review
Charles Schwab sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 401,075 shares — an estimated $21M sold.
Charles Schwab first reported a position in MNTA in Q2 2013 and held it in 30 quarters. The position peaked at $28.4M in Q2 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.
- Charles Schwab reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
- Charles Schwab sold 401,075 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $21M.
- Charles Schwab first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2013 and held it in 30 quarters.
- Charles Schwab's Momenta Pharmaceuticals, Inc. position peaked at $28.4M in Q2 2020.
- 0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.
Based on Charles Schwab's 13F filing for Q4 2020, filed 16 Feb 2021.